Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 631.29 | 628.61 | 564.93 | 470.94 |
Depreciation/ Depletion | 53.45 | 42.09 | 37.88 | 33.39 |
Non- Cash Items | 37.84 | 18.29 | 39.89 | 100.35 |
Changesin Working Capital | -309.06 | -382.99 | -45.11 | -216.57 |
Cashfrom Operating Activities | 413.52 | 306.01 | 597.59 | 388.11 |
Capital Expenditures | -128.97 | -162.80 | -132.17 | -67.99 |
Other Investing Cash Flow Items Total | 12.49 | 16.05 | 9.94 | -0.74 |
Cashfrom Investing Activities | -116.48 | -146.75 | -122.23 | -68.73 |
Financing Cash Flow Items | -1.55 | -0.55 | -0.07 | - |
Total Cash Dividends Paid | -275.69 | -385.92 | -128.65 | - |
Issuance( Retirement)of Debt Net | -2.21 | -1.13 | -961.92 | -213.78 |
Cashfrom Financing Activities | -279.44 | -387.59 | -78.80 | -213.78 |
Net Changein Cash | 17.59 | -228.33 | 396.56 | 105.60 |
Cash Interest Paid | 1.55 | 0.55 | 0.07 | - |
Cash Taxes Paid | 162.96 | 153.57 | 138.17 | 108.56 |
Issuance( Retirement)of Stock Net | - | - | 1,011.85 | 0.00 |
Alivus Life Sciences Dividend Alivus Life Sciences Bonus Alivus Life Sciences News Alivus Life Sciences AGM Alivus Life Sciences Rights Alivus Life Sciences Splits Alivus Life Sciences Board Meetings Alivus Life Sciences Key Metrics Alivus Life Sciences Shareholdings Alivus Life Sciences Profit Loss Alivus Life Sciences Balance Sheet Alivus Life Sciences Q1 Results Alivus Life Sciences Q2 Results Alivus Life Sciences Q3 Results Alivus Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks